Updated ACOG Guidelines

ACOG recommends Noninvasive Prenatal Screening Tests (NIPT) for all pregnancies regardless of age or risk factors

The American College of Obstetricians and Gynecologists (ACOG) has issued a new set of guidelines recommending that prenatal aneuploidy screening be offered to all pregnant women regardless of their age or risk factors. ACOG specifically states in the new guidelines that cfDNA assays, known as noninvasive prenatal screening tests (NIPT), offer superior sensitivity and specificity.

 Qnatal Pregnant Lady

QNatal® Advanced is a noninvasive prenatal screening test from Quest Diagnostics that offers clear, comprehensive insight:

  • Can be ordered as early as 10 weeks gestation
  • Utilizes next-generation sequencing (NGS) technology and superior bioinformatics for high sensitivity, specificity, and PPV
  • One of the lowest "no call" rates in the industry
  • Patients can choose to opt out of fetal sex and/or microdeletion reporting

To learn more, click here or speak to your Quest sales representative.

Clinical questions? Call 1.866.GENE.INFO (1.866.436.3463) to speak to one of our certified genetic counselors today.